| scholarly article | Q13442814 |
| P50 | author | Jodie Dionne-Odom | Q86426293 |
| Andrew O Westfall | Q44237002 | ||
| P2093 | author name string | Anju Bansal | |
| Paul A Goepfert | |||
| Edgar T Overton | |||
| Sarah Sterrett | |||
| Nathan Erdmann | |||
| P2860 | cites work | Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers | Q24629567 |
| HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors | Q24676982 | ||
| CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 | Q28307312 | ||
| The major genetic determinants of HIV-1 control affect HLA class I peptide presentation | Q29417018 | ||
| HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
| Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers. | Q30372415 | ||
| Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets | Q33591190 | ||
| Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control | Q33594461 | ||
| HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality | Q33618542 | ||
| Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection | Q33947817 | ||
| Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. | Q34009945 | ||
| HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses | Q34275430 | ||
| HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication | Q34448446 | ||
| Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses | Q34984762 | ||
| Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study) | Q61365620 | ||
| Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of | Q73848661 | ||
| Survival and proliferation of CD28- T cells during HIV-1 infection relate to the amplitude of viral replication | Q84142062 | ||
| Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1 | Q84444040 | ||
| Predicting AIDS-related events using CD4 percentage or CD4 absolute counts | Q35040103 | ||
| B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers | Q35058635 | ||
| HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles | Q35102172 | ||
| Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics | Q35408098 | ||
| Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells | Q35557198 | ||
| Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection | Q35661912 | ||
| HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype | Q35749755 | ||
| Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy | Q36304297 | ||
| HIV-specific CD8+ T cells from elite controllers are primed for survival. | Q36760035 | ||
| Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers | Q36862952 | ||
| Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy | Q36950611 | ||
| Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy | Q37033224 | ||
| Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control | Q37054526 | ||
| Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control | Q37169129 | ||
| Effect of antiretroviral therapy on HIV reservoirs in elite controllers | Q37212990 | ||
| Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis | Q37215251 | ||
| Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. | Q37435942 | ||
| T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors | Q37439446 | ||
| Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point | Q37473934 | ||
| An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration | Q37525462 | ||
| Evidence for innate immune system activation in HIV type 1-infected elite controllers. | Q37604465 | ||
| A systematic review of definitions of extreme phenotypes of HIV control and progression | Q38154750 | ||
| Coinhibitory receptors and CD8 T cell exhaustion in chronic infections | Q38228016 | ||
| Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection | Q39130048 | ||
| Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers | Q40659603 | ||
| Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects | Q41678934 | ||
| Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. | Q41827503 | ||
| Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. | Q42205327 | ||
| HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response. | Q42247922 | ||
| Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters | Q43070781 | ||
| Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study | Q44429168 | ||
| CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. | Q46405812 | ||
| Premature age-related comorbidities among HIV-infected persons compared with the general population | Q51000618 | ||
| Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function. | Q51981873 | ||
| Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy. | Q51993594 | ||
| CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications | Q57951557 | ||
| Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load | Q58034113 | ||
| CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men | Q58436713 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2245-2254 | |
| P577 | publication date | 2015-11-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts | |
| P478 | volume | 29 |
| Q33745355 | A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level |
| Q40045238 | A summary of the second annual HIV Microbiome workshop. |
| Q52680990 | Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers. |
| Q90779635 | HIV controllers: to treat or not to treat? Is that the right question? |
| Q58701373 | HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction |
| Q64100454 | Harnessing CD8 T Cells Under HIV Antiretroviral Therapy |
| Q59349690 | Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers |
| Q40625213 | Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation |
| Q90534685 | Plasmatic Levels of IL-18, IP-10, and Activated CD8+ T Cells Are Potential Biomarkers to Identify HIV-1 Elite Controllers With a True Functional Cure Profile |
| Q90165772 | Rapid development of HIV elite control in a patient with acute infection |
| Q57177414 | Understanding the CD8 T-cell response in natural HIV control |
Search more.